ISPH on a breakout 5.44 x 5.45. $30 Target published today in Business Week.

Inspire's Plump Pipeline
Inspire Pharmaceuticals (ISPH) has a lot going for it, including AzaSite, launched in August, 2007, to treat conjunctivitis. It also has several drugs in the pipeline, all in phase III trials: Among them are Denufosol for cystic fibrosis and Epinastine for allergic rhinitis (inflammation of nasal mucous membranes). Prolacria, for dry eye, will be in pivotal trials in 2008. AzaSite sales are expected to hit $45 million in 2008, but Denufosol could be the big driver for growth. Liana Moussatos of Pacific Growth Equities rates Inspire, now at 5.02, down from 8 in April, a buy. She values the stock at 30 in 12 months, based on the prospects of AzaSite and the other drugs. Warburg Pincus just invested $74 million in Inspire for a 25% stake. Given its late-stage drugs and Warburg's role, the stock is a buy, says David Steinberg of Deutsche Bank (DB).

ISPH on a breakout 5.44 x 5.45. $30 Target published today in Business Week.

Inspire's Plump Pipeline
Inspire Pharmaceuticals (ISPH) has a lot going for it, including AzaSite, launched in August, 2007, to treat conjunctivitis. It also has several drugs in the pipeline, all in phase III trials: Among them are Denufosol for cystic fibrosis and Epinastine for allergic rhinitis (inflammation of nasal mucous membranes). Prolacria, for dry eye, will be in pivotal trials in 2008. AzaSite sales are expected to hit $45 million in 2008, but Denufosol could be the big driver for growth. Liana Moussatos of Pacific Growth Equities rates Inspire, now at 5.02, down from 8 in April, a buy. She values the stock at 30 in 12 months, based on the prospects of AzaSite and the other drugs. Warburg Pincus just invested $74 million in Inspire for a 25% stake. Given its late-stage drugs and Warburg's role, the stock is a buy, says David Steinberg of Deutsche Bank (DB).

ISPH 5.41 x 5.43 +5.44%. Business Week article hits newsstands today with target price of $30.

Inspire's Plump Pipeline
Inspire Pharmaceuticals (ISPH) has a lot going for it, including AzaSite, launched in August, 2007, to treat conjunctivitis. It also has several drugs in the pipeline, all in phase III trials: Among them are Denufosol for cystic fibrosis and Epinastine for allergic rhinitis (inflammation of nasal mucous membranes). Prolacria, for dry eye, will be in pivotal trials in 2008. AzaSite sales are expected to hit $45 million in 2008, but Denufosol could be the big driver for growth. Liana Moussatos of Pacific Growth Equities rates Inspire, now at 5.02, down from 8 in April, a buy. She values the stock at 30 in 12 months, based on the prospects of AzaSite and the other drugs. Warburg Pincus just invested $74 million in Inspire for a 25% stake. Given its late-stage drugs and Warburg's role, the stock is a buy, says David Steinberg of Deutsche Bank (DB).

ISPH 5.41 x 5.43 +5.44%. Business Week article hits newsstands today with target price of $30.

Inspire's Plump Pipeline
Inspire Pharmaceuticals (ISPH) has a lot going for it, including AzaSite, launched in August, 2007, to treat conjunctivitis. It also has several drugs in the pipeline, all in phase III trials: Among them are Denufosol for cystic fibrosis and Epinastine for allergic rhinitis (inflammation of nasal mucous membranes). Prolacria, for dry eye, will be in pivotal trials in 2008. AzaSite sales are expected to hit $45 million in 2008, but Denufosol could be the big driver for growth. Liana Moussatos of Pacific Growth Equities rates Inspire, now at 5.02, down from 8 in April, a buy. She values the stock at 30 in 12 months, based on the prospects of AzaSite and the other drugs. Warburg Pincus just invested $74 million in Inspire for a 25% stake. Given its late-stage drugs and Warburg's role, the stock is a buy, says David Steinberg of Deutsche Bank (DB).

VSGN Breakout.. 2.32 x 2.34

VSGN Breakout.. 2.32 x 2.34

VSGN running again.. 2.28 x 2.31..

VSGN running again.. 2.28 x 2.31..

Quite impressive today, almost as impressive as your prediction of 15 cents for GMFX (now trading at a split adjusted .0000018).

VSGN.. out for now but will probably buy EOD for possible gapper.. GLTA

VSGN.. out for now but will probably buy EOD for possible gapper.. GLTA

VSGN exploding.. Printed 2.22

VSGN exploding.. Printed 2.22

VSGN 2.11 x 2.13 5X average volume

VSGN 2.11 x 2.13 5X average volume

VSGN 2.06 x 2.07

VSGN 2.06 x 2.07

VSGN HOD 1.98 x 1.99.. if it breaks 2 WOOOOOHOOOOO

VSGN HOD 1.98 x 1.99.. if it breaks 2 WOOOOOHOOOOO

VSGN.. 1.97 x 1.98.. needs to break 2

VSGN.. 1.97 x 1.98.. needs to break 2

VSGN 1.95 (4) x 1.97 (1).. Looking to break 2 today.

VSGN 1.95 (4) x 1.97 (1).. Looking to break 2 today.

WTG nice trade. E-Turd wouldn't let me buy online.

I was just notified that the post was removed today. Please note that the post was over 1 year old.

FWIW this post was also deleted from the GMFX board

Posted by: mikeisme Date:12/14/2007 11:32:48 AM
In reply to: None Post #
of 261260


Repost without naming names:

WOOHOO: I cant pm because I refuse to waste my money on a lame message board account. I of course did not buy any stock based on anyones recommendations live from this board. I did however put it in my virtual portfolio and of course it behaved like all these scam stocks on OTCBB and pink sheets behave drops like a rock. Further proof that THIS IS SCAM CITY! If you want to make the white collar thieves rich then continue to perpetuate the scam.

Nothing is worse then people who tout they're making money when in reality they are doing the opposite. I'm not saying there is no money to be made but making money on these stocks are a rarity. I'd rather donate my money to the poor then donate money to the likes of JF, HISC, Fred Wicks, Moody all these people/CEOs are crooks and recommendations from people are not much better.

Deleted from GMFX board. P&D'er in control of the board.

Posted by: WOOHOO
In reply to: mikeisme who wrote msg# 261260 Date:12/14/2007 12:13:47 PM
Post #of 261261

It's funny how posts can be deleted yet a post like this one was allowed to remain. It tells you who controls these boards.

I'm relieved to hear that you didn't fall for the trap. Best of luck to you and Happy Holidays.

Posted by: wickw50
In reply to: WOOHOO who wrote msg# 223680 Date:12/12/2006 2:15:54 PM
Post #of 261260

WooHoo, Are you still beating your wife???? unfair question ..huh....

Pittsburgh Pirates players at one time or another.

Abraham Nunez
Barry Bonds

That must explain why we haven't had a winning season since 1993 :)

http://www.cnbc.com/id/22243678

Yes I agree but there are several in there who are on the bubble in regards to the Hall of Fame.

Brady Anderson, Manny Alexander, Rick Ankiel, Jeff Bagwell, Barry Bonds, Aaron Boone, Rafaeil Bettancourt, Bret Boone, Milton Bradley, David Bell, Dante Bichette, Albert Belle, Paul Byrd, Wil Cordero, Ken Caminiti, Mike Cameron, Ramon Castro, Jose and Ozzie Canseco, Roger Clemens, Paxton Crawford, Wilson Delgado, Lenn y Dykstra, Johnny Damon, Carl Everett, Kyle Farnsoworth, Ryan Franklin, Troy Glaus, Rich Garces, Jason Grimsley, Troy Glaus, Juan Gonzalez, Eric Gagne, Nomar Garciaparra, Jason Giambi, Jeremy Giambi, Jose Guillen, Jay Gibbons, Juan Gonzalez, Clay Hensley, Jerry Hairston, Felix Heredia, Jr., Darren Holmes, Wally Joyner, Darryl Kile, Matt Lawton, Raul Mondesi, Mark McGwire, Guillermo Mota, Robert Machado, Damian Moss, Abraham Nunez, Trot Nixon, Jose Offerman, Andy Pettitte, Mark Prior, Neifi Perez, Rafael Palmiero, Albert Pujols, Brian Roberts, Juan Rincon, John Rocker, Pudge Rodriguez, Sammy Sosa, Scott Sc hoenweiis, David Segui, Alex Sanchez, Gary Sheffield, Miguel Tejada, Julian Tavarez, Fernando Tatis, Maurice Vaughn, Jason Varitek, Ismael Valdez, Matt Williams and Kerry Wood.

I am basing my no dilution assumption on the fact that the previous run started at a sub-penny PPS and although serious profit taking took place (WOOHOO) the PPS never approached the previous level before the run. I have not seen this trade below 2 cents since then. This is usually a pretty accurate sign that dilution has not occurred.

GLTY

The latest reliable information shows the O/S at 8.9M and the float at 7.2M.

I've been following this stock for most of 2007 and there has been zero dilution. This could run on any news in advance of the required Delaware SOS filing in early 2008.

GLTY

1-10 Reverse Split effective tomorrow. GLTA

12/12/2007 IYSA InteliSys Aviation Systems of America, Inc. Common Stock IAVA InteliSys Aviation Systems of America, Inc. New Common Stock 1-10 R/S **

PLX breaking out. Great call CHART!

53Chevy... doing some research on Halter Investments and saw that you've posted frequently on this subject. Can you tell me anything about them? FYI BTXX (no bid/ask) just filed a DEF 14C announcing a 1/2.86 reverse split YET they also announce to the world that they're seeking a reverse merger candidate.

Can you add anything to this?

TIA

AMENDMENT OF OUR CERTIFICATE OF INCORPORATION

On November 29, 2007, our Board of Directors approved, subject to
receiving the approval of the holders of a majority of the Company's outstanding
capital stock, an amendment to our Certificate of Incorporation to effect a
1-for-2.86 Reverse Split of Common Stock. A majority of the holders of Common
Stock approved the Amendment pursuant to the Written Consent dated as of
November 29, 2007.

The Amendment has been adopted to facilitate the Company's ability to
implement is stated business strategy of combining with a privately held entity
that has continuing business operations.

BTXX (no B/A)... has anyone played something like this before? DEF 14A filing today announces a 1/2.86 reverse split BUT also announces they are looking for a R/M candidate.

AMENDMENT OF OUR CERTIFICATE OF INCORPORATION

On November 29, 2007, our Board of Directors approved, subject to
receiving the approval of the holders of a majority of the Company's outstanding
capital stock, an amendment to our Certificate of Incorporation to effect a
1-for-2.86 Reverse Split of Common Stock. A majority of the holders of Common
Stock approved the Amendment pursuant to the Written Consent dated as of
November 29, 2007.

The Amendment has been adopted to facilitate the Company's ability to
implement is stated business strategy of combining with a privately held entity
that has continuing business operations.

Great call Chart. Researched your picks and jumped into IQW. Congrats and thank you!

Thanks for the warm welcome. I'm squeezing tight for no dramatics at the close.

GLTY

You rang?

Way to go SH!!